ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

IMCR Immunocore Holdings PLC

53,29
-0,96 (-1,77%)
17 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Immunocore Holdings PLC IMCR NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
-0,96 -1,77% 53,29 23:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
54,62 53,195 55,07 53,29 54,25
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202413:13EDGAR2Form 8-K - Current report
08.5.202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202413:00GLOBEImmunocore reports first quarter financial results and..
24.4.202416:00GLOBEImmunocore announces upcoming presentation and posters at..
04.4.202422:00GLOBEImmunocore to present at upcoming investor conferences
05.3.202422:30GLOBEImmunocore presented two posters at CROI 2024
01.3.202413:00GLOBEImmunocore to present at upcoming investor conferences
28.2.202422:19EDGAR2Form 8-K - Current report
28.2.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202413:34GLOBEImmunocore reports fourth quarter and full year 2023..
28.2.202413:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27.2.202400:46EDGAR2Form 144 - Report of proposed sale of securities
22.2.202413:00GLOBEImmunocore announces clinical trial collaboration and supply..
21.2.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202413:00GLOBEImmunocore to report fourth quarter and full year 2023..
02.2.202422:05EDGAR2Form 8-K - Current report
31.1.202405:30GLOBEImmunocore Prices Upsized Convertible Senior Notes Offering
29.1.202423:06EDGAR2Form 8-K - Current report
29.1.202422:05GLOBEImmunocore Announces Proposed Convertible Senior Notes..
05.1.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202413:19EDGAR2Form 8-K - Current report
05.1.202413:00GLOBEImmunocore announces strategic priorities and pipeline..
03.1.202423:55EDGAR2Form 144 - Report of proposed sale of securities
03.1.202413:00GLOBEImmunocore to present at the 42nd Annual J.P. Morgan..
02.1.202422:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
02.1.202412:25EDGAR2Form 8-K - Current report
27.12.202323:30EDGAR2Form 144 - Report of proposed sale of securities
20.12.202319:54EDGAR2Form 144 - Report of proposed sale of securities
01.12.202302:33EDGAR2Form 144 - Report of proposed sale of securities
30.11.202310:00GLOBELevicept Appoints Eliot Forster as CEO
16.11.202315:51EDGAR2Form 144 - Report of proposed sale of securities
07.11.202313:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.11.202313:00GLOBEImmunocore Reports Third Quarter 2023 Financial Results and..
07.11.202301:20EDGAR2Form 144 - Report of proposed sale of securities
01.11.202321:01GLOBEImmunocore announces upcoming poster presentations at SITC..
30.10.202321:30GLOBEImmunocore to present at upcoming investor conferences
21.10.202314:45GLOBEImmunocore presents three-year overall survival data from..
06.10.202313:01GLOBEImmunocore announces upcoming presentation and posters at..
02.10.202322:31EDGAR2Form 144 - Report of proposed sale of securities
11.9.202323:00GLOBEImmunocore to present at upcoming investor conferences
01.9.202322:00GLOBEImmunocore to present at upcoming investor conferences
26.8.202300:10EDGAR2Form 144 - Report of proposed sale of securities
17.8.202321:44EDGAR2Form 144 - Report of proposed sale of securities
10.8.202314:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.8.202313:00GLOBEImmunocore Reports Second Quarter 2023 Financial Results and..
03.8.202314:00GLOBEImmunocore to report second quarter 2023 financial results..
14.7.202322:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht